Environmental challenges and endocrine dysregulation have become a focal point in contemporary biomedical research due to their profound implications on human health. Recent studies have highlighted ...

If you’ve been spritzing on cologne or perfume every morning, you might want to rethink your routine. Dr. Pompa, a wellness ...

A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and disease control in patients with advanced ...

Abemaciclib plus endocrine therapy significantly improves overall survival in high-risk early breast cancer, reducing death risk by 15.8% compared to endocrine therapy alone.

The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today ...

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and drug addiction. A widely used group of medications originally developed to ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...

A practical look at the challenges of diagnosing and managing feline hyperthyroidism, from misleading symptoms to complex ...

Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...

Ferroptosis is a distinct, iron-dependent form of regulated cell death characterized by lipid peroxidation and redox imbalance. High-mobility group box 1 (HMGB1), a nuclear protein with strong ...

Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease and ...